U.S. Military Allocates $17M for Psychedelic Medicine Research

THC-Free Vegan CBD Gummies


CBD 20% Discount

The U.S. Defense Advanced Research Projects Agency (DARPA) is funding a University of North Carolina School of Medicine study on potentially using psychedelics such as ketamine and psilocybin for mental health medications.

The research is led by Dr. Bryan L. Roth, the Michael Hooker Distinguished Professor of Pharmacology, who pointed out that drugs “like ketamine and potentially psilocybin have rapid antidepressant actions” but their clinical use is limited due to their “hallucinogenic, addictive, and disorienting side effects.”

“Depression, anxiety, and substance abuse affect large segments of the population. Creating safe, rapidly acting and more effective medications would revolutionize the treatment of these disorders thereby diminishing death and disability. … Our team has developed innovative methods and technologies to overcome these limitations with the goal of creating better medications to treat these neuropsychiatric conditions.” – Roth in a statement

The four-year agreement between DARPA and the UNC School of Medicine is worth $26.9 million and features researchers from Stanford University, Icahn School of Medicine, the University of California-San Francisco, and Duke University.

Last September, psilocybin researcher Roland Griffiths announced the founding of the Center for Psychedelic and Consciousness Research at Johns Hopkins University. The center is funded by private donations of at least $17 million.

Griffiths said the center’s researchers would explore the drug as a potential treatment for alcoholism, nicotine dependence, post-traumatic stress disorder, anorexia, Alzheimer’s, and Lyme disease.

“Rapidly acting drugs with antidepressant, anti-anxiety, and anti-addictive potential devoid of disabling side effects do not exist, not even as experimental compounds for use in animals,” Roth said. “Creating such compounds would change the way we treat millions of people around the world suffering from these serious and life-threatening conditions.”

Thanks for joining us today for our latest news update. If you have any questions or comments about this post, we’d love to hear from you in the comments! Join the FindHempCBD.com newsletter to stay up to date on the latest news in Cannabis Legalization and check back soon for our next news article!

Disclaimer: This content was sourced and duplicated from Ganjapreneur.com. In order to maintain the safety, functionality, and integrity of FindHempCBD.com, the sourced content may have been altered. To access the original content, please click the link below:
U.S. Military Allocates $17M for Psychedelic Medicine Research

Discussion

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Pin It on Pinterest

Share This